Skip to content

Study on the efficacy and safety of traditional functional training in the treatment of remission of vestibular peripheral vertigo

Study on the efficacy and safety of traditional functional training in the treatment of remission of vestibular peripheral vertigo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049414
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-08-10
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Remission of vestibular peripheral vertigo

Interventions

Experimental group:traditional functional training
control group:Vestibular rehabilitation therapy

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. It accords with the diagnosis of vestibular vertigo and has a clear history of vertigo, but the sense of rotation or rotation of foreign objects has disappeared or is not obvious, and it is in the period of residual symptoms. "dizziness, instability or non-rotational vertigo" as the main symptoms. 3, non-malignant, dangerous vertigo; 4. Willing to accept traditional functional training or vestibular rehabilitation training and express understanding of this research scheme and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Non-vestibular vertigo (eye, neck, systemic diseases, blood diseases, endocrine and metabolic diseases), vestibular vertigo acute attack, vestibular vertigo after acute attack without symptoms of vestibular dysfunction; 2. Cervical spondylosis, vertebral-basilar vascular disease, cerebral arteriosclerosis, acoustic neuroma, hypertension, anemia, arrhythmia and other non-vestibular vertigo and acute hemorrhage of brain stem and cerebellum, arachnoiditis, meningitis, brain abscess, brain Dangerous central vertigo such as stem tumor and brain stem encephalitis; 3. Taking betahistine, anti-dizziness drugs, antihistamines, sedatives and other drugs that interfere with the judgment of efficacy within 2 weeks; 4. The patient is unwilling to accept the treatment methods using traditional exercises or vestibular rehabilitation training; 5. Consciousness and mental disorder, unable to cooperate with the researcher; 6. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Vertigo Disability Scale;vestibular symptom index;University of California, Los Angeles Dizziness Questionnaire;Balance confidence scale;Hospital anxiety and depression scale;Berg????;Timing balance experiment;Standing test;

Countries

China

Contacts

Public ContactXie Hui

Hospital of Chengdu University of Traditional Chinese Medicine

wangxie-ctu@163.com+86 18908172382

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026